Evotec SE ADR (EVO)
$4.62 -$0.08 (-1.70%) 4:38 PM 12/12/24
NASDAQ | $USD | Drug Manufacturers - Specialty & GenericStock Data
-
Market Cap
$1.70B -
Day's Range
$4.58 - $4.67 -
Volume
154,913 -
52 Week Low / High
$2.85 - $12.00 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
- 1
- Strong Buy
- 1
- Buy
- 2
- Hold
- 0
- Sell
- 0
- Strong Sell
- $17.60
- Target Price
Company News
-
Bolivia's Morales barred from running for political office — Nov 9th, 2024
A constitutional court in Bolivia has barred former President Evo Morales from running again for office, ushering in a new phase in the country's long-running political crisis....
-
Bolivia's Morales barred from running for political office — Nov 9th, 2024
A constitutional court in Bolivia has barred former President Evo Morales from running again for office, ushering in a new phase in the country's long-running political crisis....
-
Bolivia's Morales barred from running for political office — Nov 9th, 2024
A constitutional court in Bolivia has barred former President Evo Morales from running again for office, ushering in a new phase in the country's long-running political crisis....
-
Even after rising 11% this past week, Evotec (ETR:EVT) shareholders are still down 84% over the past three years — Oct 1st, 2024
This week we saw the Evotec SE (ETR:EVT) share price climb by 11%. But the last three years have seen a terrible decline. The share price has sunk like a leaky ship, down 84% in that time. So we're relieved for long term holders to see a bit of uplift. The thing to think about is whether t...
-
Evotec and Novo Nordisk Enter into Technology Development Partnership to Support Next-Generation Cell Therapies — Sep 26th, 2024
Novo Nordisk will provide funding for technology development activities at Evotec to support clinical and commercial manufacturing of stem cell-based therapies HAMBURG, GERMANY / ACCESSWIRE / September 26, 2024 / Evotec SE (Frankfurt Stock Exchange:EVT, SDAX/TecDAX, ISIN: DE0005664809; NA...
-
Even after rising 11% this past week, Evotec (ETR:EVT) shareholders are still down 84% over the past three years — Oct 1st, 2024
This week we saw the Evotec SE (ETR:EVT) share price climb by 11%. But the last three years have seen a terrible decline. The share price has sunk like a leaky ship, down 84% in that time. So we're relieved for long term holders to see a bit of uplift. The thing to think about is whether t...
-
Bolivia's Morales barred from running for political office — Nov 9th, 2024
A constitutional court in Bolivia has barred former President Evo Morales from running again for office, ushering in a new phase in the country's long-running political crisis....
-
Bolivia's Morales barred from running for political office — Nov 9th, 2024
A constitutional court in Bolivia has barred former President Evo Morales from running again for office, ushering in a new phase in the country's long-running political crisis....
-
Bolivia's Morales barred from running for political office — Nov 9th, 2024
A constitutional court in Bolivia has barred former President Evo Morales from running again for office, ushering in a new phase in the country's long-running political crisis....
-
Bolivia's Morales barred from running for political office — Nov 9th, 2024
A constitutional court in Bolivia has barred former President Evo Morales from running again for office, ushering in a new phase in the country's long-running political crisis....
-
Even after rising 11% this past week, Evotec (ETR:EVT) shareholders are still down 84% over the past three years — Oct 1st, 2024
This week we saw the Evotec SE (ETR:EVT) share price climb by 11%. But the last three years have seen a terrible decline. The share price has sunk like a leaky ship, down 84% in that time. So we're relieved for long term holders to see a bit of uplift. The thing to think about is whether t...
-
Bolivia's Morales barred from running for political office — Nov 9th, 2024
A constitutional court in Bolivia has barred former President Evo Morales from running again for office, ushering in a new phase in the country's long-running political crisis....
-
Even after rising 11% this past week, Evotec (ETR:EVT) shareholders are still down 84% over the past three years — Oct 1st, 2024
This week we saw the Evotec SE (ETR:EVT) share price climb by 11%. But the last three years have seen a terrible decline. The share price has sunk like a leaky ship, down 84% in that time. So we're relieved for long term holders to see a bit of uplift. The thing to think about is whether t...
-
Bolivia's Morales barred from running for political office — Nov 9th, 2024
A constitutional court in Bolivia has barred former President Evo Morales from running again for office, ushering in a new phase in the country's long-running political crisis....
-
Even after rising 11% this past week, Evotec (ETR:EVT) shareholders are still down 84% over the past three years — Oct 1st, 2024
This week we saw the Evotec SE (ETR:EVT) share price climb by 11%. But the last three years have seen a terrible decline. The share price has sunk like a leaky ship, down 84% in that time. So we're relieved for long term holders to see a bit of uplift. The thing to think about is whether t...
-
Even after rising 11% this past week, Evotec (ETR:EVT) shareholders are still down 84% over the past three years — Oct 1st, 2024
This week we saw the Evotec SE (ETR:EVT) share price climb by 11%. But the last three years have seen a terrible decline. The share price has sunk like a leaky ship, down 84% in that time. So we're relieved for long term holders to see a bit of uplift. The thing to think about is whether t...
-
Even after rising 11% this past week, Evotec (ETR:EVT) shareholders are still down 84% over the past three years — Oct 1st, 2024
This week we saw the Evotec SE (ETR:EVT) share price climb by 11%. But the last three years have seen a terrible decline. The share price has sunk like a leaky ship, down 84% in that time. So we're relieved for long term holders to see a bit of uplift. The thing to think about is whether t...
-
Bolivia's Morales barred from running for political office — Nov 9th, 2024
A constitutional court in Bolivia has barred former President Evo Morales from running again for office, ushering in a new phase in the country's long-running political crisis....
-
Bolivia's Morales barred from running for political office — Nov 9th, 2024
A constitutional court in Bolivia has barred former President Evo Morales from running again for office, ushering in a new phase in the country's long-running political crisis....
-
Bolivia's Morales barred from running for political office — Nov 9th, 2024
A constitutional court in Bolivia has barred former President Evo Morales from running again for office, ushering in a new phase in the country's long-running political crisis....
-
Evotec and Novo Nordisk Enter into Technology Development Partnership to Support Next-Generation Cell Therapies — Sep 26th, 2024
Novo Nordisk will provide funding for technology development activities at Evotec to support clinical and commercial manufacturing of stem cell-based therapies HAMBURG, GERMANY / ACCESSWIRE / September 26, 2024 / Evotec SE (Frankfurt Stock Exchange:EVT, SDAX/TecDAX, ISIN: DE0005664809; NA...
-
Bolivia's Morales barred from running for political office — Nov 9th, 2024
A constitutional court in Bolivia has barred former President Evo Morales from running again for office, ushering in a new phase in the country's long-running political crisis....
-
Bolivia's Morales barred from running for political office — Nov 9th, 2024
A constitutional court in Bolivia has barred former President Evo Morales from running again for office, ushering in a new phase in the country's long-running political crisis....
-
Even after rising 11% this past week, Evotec (ETR:EVT) shareholders are still down 84% over the past three years — Oct 1st, 2024
This week we saw the Evotec SE (ETR:EVT) share price climb by 11%. But the last three years have seen a terrible decline. The share price has sunk like a leaky ship, down 84% in that time. So we're relieved for long term holders to see a bit of uplift. The thing to think about is whether t...
-
Bolivia's Morales barred from running for political office — Nov 9th, 2024
A constitutional court in Bolivia has barred former President Evo Morales from running again for office, ushering in a new phase in the country's long-running political crisis....
-
Evotec and Novo Nordisk Enter into Technology Development Partnership to Support Next-Generation Cell Therapies — Sep 26th, 2024
Novo Nordisk will provide funding for technology development activities at Evotec to support clinical and commercial manufacturing of stem cell-based therapies HAMBURG, GERMANY / ACCESSWIRE / September 26, 2024 / Evotec SE (Frankfurt Stock Exchange:EVT, SDAX/TecDAX, ISIN: DE0005664809; NA...
Portfolio
Comprised of 1 portfolios